September 15, 2025 - 09:53

Alan Lightman’s new book, “The Shape of Wonder,” co-authored with Martin Rees, delves into the lives and methodologies of prominent scientists, aiming to humanize these often-misunderstood figures. Through engaging profiles, the authors reveal the personal stories and experiences that shape the work of these researchers, highlighting their passions, struggles, and triumphs.
The book not only showcases the scientific methods employed by these individuals but also emphasizes the emotional and ethical dimensions of their research. By presenting scientists as relatable figures, Lightman and Rees argue for the importance of their contributions to society and the broader understanding of the universe.
This exploration provides readers with a deeper appreciation for the challenges scientists face and the motivations driving their discoveries. In doing so, “The Shape of Wonder” makes a compelling case for the value of scientific inquiry and the need to recognize the humanity behind the lab coats.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...